个人中心| | 帮助
高级检索
当前位置： 首页 > 详情页

Global burden of prostate cancer attributable to smoking among males in 204 countries and territories, 1990-2019

| 认领 | 导出 | |

文献详情

资源类型：
WOS体系：
Pubmed体系：

收录情况： ◇ SCIE

作者：
Zhang Hanfei[1,2] ; Huang Dingping[3] ; Zhang Yingfeng[1] ; Wang Xia[4] ; Wu Jiangtao[5] ; Hong Daqing[1,2,6] ;
机构： [1]School of Medicine, University of Electronic Science and Technology of China, Chengdu, China. [2]Department of Nephrology, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, Chengdu, China. [3]Department of Urology, Zhongshan Hospital, Xiamen University, Xiamen, China. [4]The George Institute for Global Health, University of New South Wales, Level 5, 1 King Street, Newtown, NSW, 2042, Australia. [5]Department of Urology, Xuanwu Hospital, Capital Medical University, Beijing, 100053, China. [6]Renal Department and Nephrology Institute, School of Medicine, Sichuan Provincial People’s Hospital, University of Electronic Science and Technology of China, Chengdu 610072, China.
出处：
DOI： 10.1186/s12885-023-10552-8
ISSN：

关键词： Burden of disease GBD study Prostate cancer Smoking Mortality Disability-adjusted life-years

摘要：
Understanding the latest global spatio-temporal pattern of prostate cancer burden attributable to smoking can help guide effective global health policy. This study aims to elucidate the trends in smoking-related prostate cancer from 1990 to 2019 using Global Burden of Disease (GBD) 2019 study data.Data on prostate cancer attributable to smoking were extracted from Global Burden of Disease Study (GBD) 2019. The numbers and age-standardized rates on smoking-related prostate cancer mortality (ASMR) and disability-adjusted life years (ASDR) were analyzed by year, age, region, country, and socio-demographic index (SDI) level. Estimated annual percentage change (EAPC) was calculated to evaluate the temporal trends of ASMR and ASDR from 1990 to 2019.Of all prostate cancer deaths and DALYs globally in 2019, 6% and 6.6% were attributable to smoking, which contributed to 29,298 (95% CI 12,789 to 46,609) deaths and 571,590 (95% CI 253,490 to 917,820) disability-adjusted life-years (DALYs) in 2019. The number of smoking-related deaths and DALYs showed an upward trend, increasing by half from 1990 to 2019, while ASMR and ASDR declined in five sociodemographic indexes (SDI) regions, with the fastest decline in high SDI regions. For geographical regions, Western Europe and East Asia were the high-risk areas of prostate cancer deaths and DALYs attributable to smoking, among which China and the United States were the countries with the heaviest burden. The ASMR has decreased in all age groups, with the fastest decrease occurring in 75-79 years old. The ASMR or ASDR tended to increase in countries with the lowest SDI, but declined in countries with the highest SDI. The EAPC in ASMR or ASDR was highly negatively correlated with Human Development Index (HDI) in 2019, with coefficients 0.46.The number of smoking-related prostate cancer deaths and DALYs continued to increase globally, whereas its ASMR and ASDR have been decreasing. This substantial progress is particularly significant in developed regions and vary across geographic regions. Medical strategies to prevent and reduce the burden should be adjusted and implemented based on country-specific disease prevalence.© 2023. The Author(s).

语种：
外文
被引次数：
WOS：
PubmedID：
中科院(CAS)分区：
出版当年[2023]版：
大类 | 2 区 医学
小类 | 3 区 肿瘤学
最新[2023]版：
大类 | 2 区 医学
小类 | 3 区 肿瘤学
JCR分区：
出版当年[2023]版：
Q2 ONCOLOGY
最新[2023]版：
Q2 ONCOLOGY

影响因子： 最新[2023版] 最新五年平均 出版当年[2023版] 出版当年五年平均 出版前一年[2022版]

第一作者：
第一作者机构： [1]School of Medicine, University of Electronic Science and Technology of China, Chengdu, China. [2]Department of Nephrology, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, Chengdu, China.
共同第一作者：
通讯作者：
通讯机构： [1]School of Medicine, University of Electronic Science and Technology of China, Chengdu, China. [2]Department of Nephrology, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, Chengdu, China. [6]Renal Department and Nephrology Institute, School of Medicine, Sichuan Provincial People’s Hospital, University of Electronic Science and Technology of China, Chengdu 610072, China.
推荐引用方式(GB/T 7714)：
Zhang Hanfei,Huang Dingping,Zhang Yingfeng,et al.Global burden of prostate cancer attributable to smoking among males in 204 countries and territories, 1990-2019[J].BMC CANCER.2023,23(1):doi:10.1186/s12885-023-10552-8.
APA：
Zhang Hanfei,Huang Dingping,Zhang Yingfeng,Wang Xia,Wu Jiangtao&Hong Daqing.(2023).Global burden of prostate cancer attributable to smoking among males in 204 countries and territories, 1990-2019.BMC CANCER,23,(1)
MLA：
Zhang Hanfei,et al."Global burden of prostate cancer attributable to smoking among males in 204 countries and territories, 1990-2019".BMC CANCER 23..1(2023)

相关文献

[1]Global, regional, and national cancer burdens of respiratory and digestive tracts in 1990-2044: A cross-sectional and age-period-cohort forecast study [2]Epidemiological and demographic drivers of lung cancer mortality from 1990 to 2019: results from the global burden of disease study 2019 [3]Global, regional, and national levels and causes of maternal mortality during 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. [4]State-level disparities in burden of ischemic heart diseases mortality attributable to ambient fine particulate matter in the United States, 1990-2019: Observational analysis for the Global Burden of Disease (2019) study [5]Burden of Lung Cancer in China, 1990-2019: Findings from the Global Burden of Disease Study 2019 [6]The temporal trend of disease burden attributable to metabolic risk factors in China, 1990-2019: An analysis of the Global Burden of Disease study [7]Global, regional, and national burden of female cancers in women of child-bearing age, 1990-2021: analysis of data from the global burden of disease study 2021 [8]Epidemiology of liver diseases: global disease burden and forecasted research trends [9]Synergy of arsenic with smoking in causing cardiovascular disease mortality: A cohort study with 27 follow-up years in China [10]The effect of statins on prostate cancer recurrence and mortality after definitive therapy: a systematic review and meta-analysis.

资源点击量：46424 今日访问量：0 总访问量：3323 更新日期：2024-11-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 四川省肿瘤医院 技术支持：重庆聚合科技有限公司 地址：成都市人民南路四段55号